Canada markets closed

Assure Holdings Corp. (IOM.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
1.00000.0000 (0.00%)
At close: 3:49PM EDT
Full screen
Previous Close1.0000
Open0.9900
Bid0.9200 x 0
Ask1.0800 x 0
Day's Range0.9900 - 1.0000
52 Week Range0.8100 - 2.4000
Volume1,000
Avg. Volume12,941
Market Cap34.921M
Beta (5Y Monthly)1.74
PE Ratio (TTM)500.00
EPS (TTM)0.0020
Earnings DateAug. 28, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
  • GlobeNewswire

    Assure Holdings Sets Second Quarter 2020 Conference Call for Friday, August 28, 2020, at 11:00 a.m. ET

    DENVER, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Friday, August 28, 2020, at 11:00 a.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2020. The Company will report its financial results in a press release prior to the conference call. Assure’s executive chairman and CEO John Farlinger, CFO Trent Carman and Founder Preston Parsons will host the conference call, followed by a question and answer period.Date: Friday, August 28, 2020 Time: 11:00 a.m. Eastern time (9:00 a.m. Mountain time) Toll-free dial-in number: 1-877-407-0792 International dial-in number: 1-201-689-8263 Conference ID: 13708176Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization.The conference call will be broadcast live and available for replay here.A replay of the conference call will be available after 2:00 p.m. Eastern time on the same day through September 11, 2020.Toll-free replay number: 1-844-512-2921 International replay number: 1-412-317-6671 Replay ID: 13708176About Assure Holdings Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commission’s Gold Seal of Approval®. For more information, visit the Company’s website at www.assureneuromonitoring.com.Forward-Looking Statements This news release may contain “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and economic activity in general, and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Contact Scott Kozak, Investor and Media Relations Assure Holdings Corp. 1-720-287-3093 Scott.Kozak@assureiom.comJohn Farlinger, Chief Executive Officer Assure Holdings Corp. 1-604-763-7565 John.Farlinger@assureiom.com

  • GlobeNewswire

    Assure to Attend Investor Conferences in August and September 2020

    DENVER, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that management will participate in the following investor conferences in August and September 2020: * Lytham Partners Virtual Investor Growth Conference on August 19-21, 2020. Management will be participating in virtual one-on-one meetings with institutional investors. To arrange a meeting, please contact Adam Lowensteiner of Lytham Partners at lowensteiner@lythampartners.com or visit www.lythampartners.com/virtual. * LD Micro 500 Virtual Investor Conference on September 1-4, 2020. More than 350 participating companies will provide updates to investors. Assure’s executive chairman and CEO John Farlinger is scheduled to present on September 1st at 12:20 p.m. ET with one-on-one meetings held throughout the conference. Register for the LD 500 Conference here: https://ld-micro-conference.events.issuerdirect.com/. * The Life Sciences Investor Forum on September 17, 2020. Assure management is scheduled to present on September 17th at 11:00 a.m. ET. The audience for this conference includes individual and institutional investors and wealth management professionals. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. While attendance at this virtual event is free, it is recommended that investors pre-register at https://lifesciencesinvestorforum.gcs-web.com/events/event-details/agenda.Settlement of Debt with Arm’s Length Creditor Assure announces that further to its news release on July 14, 2020,  it has issued 50,000 common shares (the “Common Shares”) in the capital of the Company at a deemed price of US$0.81 per share to settle US$40,500 of debt owed to an arm’s length creditor (the “Debt Settlement”). The Common Shares are subject to a hold period of twelve months following the date of issuance thereof, in accordance with the policies of the TSX Venture Exchange (the “TSXV”) and applicable Canadian and U.S. securities laws. The Debt Settlement was accepted by the TSXV on July 28, 2020.About Assure Holdings Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission’s Gold Seal of Approval®. For more information, visit the company’s website at www.assureneuromonitoring.com.Forward-Looking Statements This news release may contain “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and economic activity in general, and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Contact Scott Kozak, Investor and Media Relations Assure Holdings Corp. 1-720-287-3093 Scott.Kozak@assureiom.com

  • ACCESSWIRE

    LD Micro Announces Preliminary List of Presenters for the LD-500.

    LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.